Gender differences in depression and response to psychotropic medication (Q36543614)

14 August 2017

1 reference

title

Gender differences in depression and response to psychotropic medication (English)

1 reference

14 August 2017

Jack M Gorman

1

1 reference

14 August 2017

1 June 2006

1 reference

14 August 2017

1 reference

14 August 2017

3

1 reference

14 August 2017

93-109

1 reference

14 August 2017

2

1 reference

Cross-national epidemiology of major depression and bipolar disorder

14 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Excess mortality in panic disorder. A comparison with primary unipolar depression.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Assessment and treatment of suicidal patients

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Are depressive symptoms a risk factor for mortality in elderly Japanese American men?: the Honolulu-Asia Aging Study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Depression as an antecedent to heart disease among women and men in the NHANES I study. National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Depression and cardiac mortality: results from a community-based longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Depression as a contributing factor in cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Depression: a major, unrecognized risk factor for osteoporosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Bone mineral density in women with depression.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

The association of bone mineral density and depression in an older population

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Depression and poor glycemic control: a meta-analytic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Psychological and social correlates of glycemic control.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

The effectiveness of depression care management on diabetes-related outcomes in older patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Association of depression with medical illness: does cortisol play a role?

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Clinical practice. Adolescent depression

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Somatized depression in primary care attenders

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Clinically significant drug interactions with antidepressants in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Antidepressant adherence and suicide risk in depressed youth

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Antidepressants and the risk of suicidal behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

The relationship between antidepressant medication use and rate of suicide

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Relationship Between Antidepressant Medication Treatment and Suicide in Adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Gender differences in treatment response to sertraline versus imipramine in chronic depression

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Are there differences between women's and men's antidepressant responses?

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Are gender differences important for the clinical effects of antidepressants?

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Response to tricyclic antidepressants: independent of gender?

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Premenstrual Dysphoric Disorder: Recognition and Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Controlled clinical trial of interpersonal psychotherapy versus parenting education program for depressed pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Pharmacologic treatment of depression during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Outcomes of prenatal antidepressant exposure

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

The safety of newer antidepressants in pregnancy and breastfeeding

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of fluoxetine.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

A multicentre prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Newer antidepressants in pregnancy: prospective outcome of a case series

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Transplacental transfer of citalopram, fluoxetine and their primary demethylated metabolites in isolated perfused human placenta

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Placental passage of antidepressant medications

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Benefits and risks to mother and infant of drug treatment for postnatal depression

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Efficacy of interpersonal psychotherapy for postpartum depression

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Investigation of pharmacokinetics and of possible adverse effects in infants exposed to tricyclic antidepressants in breast-milk.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

The use of tricyclic antidepressants and selective serotonin reuptake inhibitors in women who are breastfeeding

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Prevention of postpartum depression: a pilot randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Childhood sexual abuse and psychiatric disorder in young adulthood: II. Psychiatric outcomes of childhood sexual abuse

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

The prevalence of sexual abuse among adolescents in school

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Early sexual abuse and clinical depression in adult life

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Childhood sexual abuse and mental health in adult life

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Age of onset of sexual abuse: relationship to sexually inappropriate behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Childhood sexual abuse as a risk factor for depression in women: psychosocial and neurobiological correlates

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

The relative influence of childhood sexual abuse and other family background risk factors on adult adversities in female outpatients treated for anxiety disorders and depression.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Childhood physical and sexual abuse in patients with anxiety disorders and in a community sample

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

HISTORY OF CHILDHOOD ABUSE IN PANIC DISORDER, SOCIAL PHOBIA, AND GENERALIZED ANXIETY DISORDER

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Post-traumatic stress disorder in the community: an epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Biologic findings of post-traumatic stress disorder and child maltreatment

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Influence of neonatal rearing conditions on stress-induced adrenocorticotropin responses and norepinepherine release in the hypothalamic paraventricular nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Long-term adaptations in glucocorticoid receptor and mineralocorticoid receptor mRNA and negative feedback on the hypothalamo-pituitary-adrenal axis following neonatal maternal separation

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Controversies surrounding glucocorticoid-mediated cell death in the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Rapid reversal of psychotic depression using mifepristone

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Toward individualized evidence-based medicine: five "N of 1" trials of methylphenidate in geriatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Effects of methylphenidate in HIV-related depression: a comparative trial with desipramine

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Methylphenidate for depression in hospice practice: a case series

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

A phase II study of methylphenidate for depression in advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Palliative Uses of Methylphenidate in Patients With Cancer: A Review

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: an open trial

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Efficacy of Citalopram as a Monotherapy or as an Adjunctive Treatment to Estrogen Therapy for Perimenopausal and Postmenopausal Women With Depression and Vasomotor Symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Estrogen replacement therapy and antidepressant response to sertraline in older depressed women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Estrogen stimulates a transient increase in the number of new neurons in the dentate gyrus of the adult female rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Gonadal Steroid Action on the Brain: Neurochemistry and Neuropharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

Hormonal effects on the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980199-3

7 January 2021

10.1016/S1550-8579(06)80199-3

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16860269